Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 27 of GRI Bio, Inc.'s SEC filings and found 19 warrant series, 1 ATM program, 4 shelf registrations, 2 S-1 registrations and 1 completed offering on file for GRI. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 6, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
ERNAErnexa Therapeutics Inc.
KALAKALA BIO, Inc.
JUNSJupiter Neurosciences, Inc.
APVOAptevo Therapeutics Inc.
SXTP60 Degrees Pharmaceuticals, Inc.
LIMNLiminatus Pharma, Inc. Class A Common Stock
CMNDClearmind Medicine Inc.
PMCBPharmaCyte Biotech, Inc.
DRMADermata Therapeutics, Inc.
MDCXMedicus Pharma Ltd. Common Stock
CVKDCadrenal Therapeutics, Inc. Common Stock
REVBRevelation Biosciences, Inc.
BDRXBiodexa Pharmaceuticals plc American Depositary Shs
CODXCo-Diagnostics, Inc.
ONCOOnconetix, Inc.